{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:21:16Z","timestamp":1792462876037,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Experimental models of cardiovascular diseases largely depend on the genetic background. Subtotal 5\/6 nephrectomy (5\/6 Nx) is the most frequently used model of chronic kidney disease (CKD) in rodents. However, in mice, cardiovascular consequences of 5\/6 Nx are rarely reported in details and comparative results between strains are scarce. The present study detailed and compared the outcomes of 5\/6 Nx in the 2 main strains of mice used in cardiovascular and kidney research, 129\/Sv and C57BL\/6JRj. Twelve weeks after 5\/6 Nx, CKD was demonstrated by a significant increase in plasma creatinine in both 129\/Sv and C57BL\/6JRj male mice. Polyuria and kidney histological lesions were more pronounced in 129\/Sv than in C57BL\/6JRj mice. Increase in albuminuria was significant in 129\/Sv but not in C57BL\/6JRj mice. Both strains exhibited an increase in systolic blood pressure after 8 weeks associated with decreases in cardiac systolic and diastolic function. Heart weight increased significantly only in 129\/Sv mice. Endothelium-dependent mesenteric artery relaxation to acetylcholine was altered after 5\/6 Nx in C57BL\/6JRj mice. Marked reduction of endothelium-dependent vasodilation to increased intraluminal flow was demonstrated in both strains after 5\/6 Nx. Cardiovascular and kidney consequences of 5\/6 Nx were more pronounced in 129\/Sv than in C57BL\/6JRj mice.<\/jats:p>","DOI":"10.1038\/s41598-020-58393-w","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:02:57Z","timestamp":1580382177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["5\/6 nephrectomy induces different renal, cardiac and vascular consequences in 129\/Sv and C57BL\/6JRj mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Mouad","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4022-7889","authenticated-orcid":false,"given":"Zoubir","family":"Djerada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0590-0158","authenticated-orcid":false,"given":"Vincent","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Bellien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-5785","authenticated-orcid":false,"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"58393_CR1","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill, N. R. et al. Global Prevalence of Chronic Kidney Disease \u2013 A Systematic Review and Meta-Analysis. PLOS ONE 11, e0158765 (2016).","journal-title":"PLOS ONE"},{"key":"58393_CR2","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","volume":"35","author":"M Gori","year":"2014","unstructured":"Gori, M. et al. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur. Heart J. 35, 3442\u20133451 (2014).","journal-title":"Eur. Heart J."},{"key":"58393_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296\u20131305 (2004).","journal-title":"N. Engl. J. Med."},{"key":"58393_CR4","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1681\/ASN.2012020145","volume":"23","author":"M Park","year":"2012","unstructured":"Park, M. et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J. Am. Soc. Nephrol. JASN 23, 1725\u20131734 (2012).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"58393_CR5","first-page":"3537","volume":"26","author":"MI Yilmaz","year":"2011","unstructured":"Yilmaz, M. I. et al. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 26, 3537\u20133543 (2011).","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc."},{"key":"58393_CR6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2215\/CJN.12811216","volume":"12","author":"T Kopel","year":"2017","unstructured":"Kopel, T. et al. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease. Clin. J. Am. Soc. Nephrol. CJASN 12, 1588\u20131594 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"58393_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","volume":"12","author":"JC Schefold","year":"2016","unstructured":"Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D. & von Haehling, S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat. Rev. Nephrol. 12, 610\u2013623 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"58393_CR8","doi-asserted-by":"crossref","unstructured":"Yoshida, T., Yamashita, M., Horimai, C. & Hayashi, M. Smooth Muscle\u2013Selective Nuclear Factor\u2010\u03baB Inhibition Reduces Phosphate\u2010Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 6 (2017).","DOI":"10.1161\/JAHA.117.007248"},{"key":"58393_CR9","doi-asserted-by":"publisher","first-page":"F192","DOI":"10.1152\/ajprenal.00146.2006","volume":"292","author":"A Erdely","year":"2007","unstructured":"Erdely, A., Freshour, G., Tain, Y.-L., Engels, K. & Baylis, C. DOCA\/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains. Am. J. Physiol. Renal Physiol. 292, F192\u2013196 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"58393_CR10","doi-asserted-by":"publisher","first-page":"F785","DOI":"10.1152\/ajprenal.00488.2015","volume":"310","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R. et al. Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL\/6 mice. Am. J. Physiol. Renal Physiol. 310, F785\u2013F795 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"58393_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12882-017-0694-3","volume":"18","author":"MA Masum","year":"2017","unstructured":"Masum, M. A., Ichii, O., Elewa, Y. H. A., Nakamura, T. & Kon, Y. Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions. BMC Nephrol. 18, 280 (2017).","journal-title":"BMC Nephrol."},{"key":"58393_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/ndt\/gfx332","volume":"33","author":"S Neuburg","year":"2018","unstructured":"Neuburg, S. et al. Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrol. Dial. Transplant. 33, 1129\u20131137 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"key":"58393_CR13","doi-asserted-by":"publisher","first-page":"e0196684","DOI":"10.1371\/journal.pone.0196684","volume":"13","author":"D Landau","year":"2018","unstructured":"Landau, D., London, L., Bandach, I. & Segev, Y. The hypoxia inducible factor\/erythropoietin (EPO)\/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia. PloS One 13, e0196684 (2018).","journal-title":"PloS One"},{"key":"58393_CR14","doi-asserted-by":"publisher","first-page":"e0190820","DOI":"10.1371\/journal.pone.0190820","volume":"13","author":"E Gravesen","year":"2018","unstructured":"Gravesen, E. et al. Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification. PloS One 13, e0190820 (2018).","journal-title":"PloS One"},{"key":"58393_CR15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/jcmm.12813","volume":"20","author":"J Yin","year":"2016","unstructured":"Yin, J. et al. Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy. J. Cell. Mol. Med. 20, 1106\u20131117 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"58393_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddmod.2010.08.002","volume":"7","author":"H-C Yang","year":"2010","unstructured":"Yang, H.-C., Zuo, Y. & Fogo, A. B. Models of chronic kidney disease. Drug Discov. Today Dis. Models 7, 13\u201319 (2010).","journal-title":"Drug Discov. Today Dis. Models"},{"key":"58393_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ki.2010.287","volume":"78","author":"A Leelahavanichkul","year":"2010","unstructured":"Leelahavanichkul, A. et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 78, 1136\u20131153 (2010).","journal-title":"Kidney Int."},{"key":"58393_CR18","doi-asserted-by":"publisher","first-page":"e002895","DOI":"10.1161\/CIRCHEARTFAILURE.115.002895","volume":"9","author":"J Maupoint","year":"2016","unstructured":"Maupoint, J. et al. Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure. Circ. Heart Fail. 9, e002895 (2016).","journal-title":"Circ. Heart Fail."},{"key":"58393_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.yjmcc.2012.03.003","volume":"52","author":"E Gomez","year":"2012","unstructured":"Gomez, E. et al. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B. J. Mol. Cell. Cardiol. 52, 1257\u20131264 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"58393_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.106.630129","volume":"114","author":"M Vercauteren","year":"2006","unstructured":"Vercauteren, M. et al. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 114, 2498\u20132507 (2006).","journal-title":"Circulation"},{"key":"58393_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1523-1755.2003.00058.x","volume":"64","author":"L-J Ma","year":"2003","unstructured":"Ma, L.-J. & Fogo, A. B. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 64, 350\u2013355 (2003).","journal-title":"Kidney Int."},{"key":"58393_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ki.2008.690","volume":"75","author":"AM Siedlecki","year":"2009","unstructured":"Siedlecki, A. M., Jin, X. & Muslin, A. J. Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int. 75, 800\u2013808 (2009).","journal-title":"Kidney Int."},{"key":"58393_CR23","doi-asserted-by":"publisher","first-page":"e001852","DOI":"10.1161\/JAHA.115.001852","volume":"4","author":"H Han","year":"2015","unstructured":"Han, H. et al. p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes. J. Am. Heart Assoc. 4, e001852 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"58393_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/hr.2009.25","volume":"32","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Angiotensin (1\u20137) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5\/6 nephrectomy mice. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 32, 369\u2013374 (2009).","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"key":"58393_CR25","doi-asserted-by":"crossref","unstructured":"Winterberg, P. D., Jiang, R., Maxwell, J. T., Wang, B. & Wagner, M. B. Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD). Physiol. Rep. 4 (2016).","DOI":"10.14814\/phy2.12732"},{"key":"58393_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(16)30508-6","volume":"388","author":"C Wanner","year":"2016","unstructured":"Wanner, C., Amann, K. & Shoji, T. The heart and vascular system in dialysis. Lancet Lond. Engl. 388, 276\u2013284 (2016).","journal-title":"Lancet Lond. Engl."},{"key":"58393_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.amjcard.2012.11.025","volume":"111","author":"B Sato","year":"2013","unstructured":"Sato, B. et al. Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction. Am. J. Cardiol. 111, 712\u2013716 (2013).","journal-title":"Am. J. Cardiol."},{"key":"58393_CR28","first-page":"717","volume":"67","author":"A Gueret","year":"2016","unstructured":"Gueret, A. et al. Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction. Hypertens. Dallas Tex 1979 67, 717\u2013723 (2016).","journal-title":"Hypertens. Dallas Tex 1979"},{"key":"58393_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.kint.2016.10.035","volume":"91","author":"R Kobayashi","year":"2017","unstructured":"Kobayashi, R. et al. An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model. Kidney Int. 91, 1115\u20131125 (2017).","journal-title":"Kidney Int."},{"key":"58393_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1067\/mhj.2002.119895","volume":"143","author":"K Wachtell","year":"2002","unstructured":"Wachtell, K. et al. Urine albumin\/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am. Heart J. 143, 319\u2013326 (2002).","journal-title":"Am. Heart J."},{"key":"58393_CR31","doi-asserted-by":"publisher","unstructured":"Chong, J., Fotheringham, J., Tomson, C. & Ellam, T. Renal albumin excretion in healthy young adults and its association with mortality risk in the US population. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc., https:\/\/doi.org\/10.1093\/ndt\/gfy242 (2018).","DOI":"10.1093\/ndt\/gfy242"},{"key":"58393_CR32","doi-asserted-by":"publisher","first-page":"F788","DOI":"10.1152\/ajprenal.90515.2008","volume":"298","author":"SB Gurley","year":"2010","unstructured":"Gurley, S. B. et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+\/C96Y) (Akita) mice. Am. J. Physiol. Renal Physiol. 298, F788\u2013795 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"58393_CR33","first-page":"e87","volume":"73","author":"LO Lerman","year":"2019","unstructured":"Lerman, L. O. et al. Animal Models of Hypertension: A Scientific Statement From the American Heart Association. Hypertens. Dallas Tex 1979 73, e87\u2013e120 (2019).","journal-title":"Hypertens. Dallas Tex 1979"},{"key":"58393_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2018.12.034","volume":"96","author":"JM Luther","year":"2019","unstructured":"Luther, J. M. & Fogo, A. B. Under pressure-how to assess blood pressure in rodents: tail-cuff? Kidney Int. 96, 34\u201336 (2019).","journal-title":"Kidney Int."},{"key":"58393_CR35","doi-asserted-by":"publisher","first-page":"e11979","DOI":"10.1371\/journal.pone.0011979","volume":"5","author":"O Jung","year":"2010","unstructured":"Jung, O. et al. Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease. PloS One 5, e11979 (2010).","journal-title":"PloS One"},{"key":"58393_CR36","doi-asserted-by":"publisher","first-page":"F1008","DOI":"10.1152\/ajprenal.00574.2017","volume":"314","author":"J Wei","year":"2018","unstructured":"Wei, J. et al. A new low-nephron CKD model with hypertension, progressive decline of renal function, and enhanced inflammation in C57BL\/6 mice. Am. J. Physiol. Renal Physiol. 314, F1008\u2013F1019 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"58393_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2005080834","volume":"17","author":"F Stam","year":"2006","unstructured":"Stam, F. et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J. Am. Soc. Nephrol. JASN 17, 537\u2013545 (2006).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"58393_CR38","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.bbrc.2017.12.069","volume":"495","author":"T Li","year":"2018","unstructured":"Li, T., Gua, C., Wu, B. & Chen, Y. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease. Biochem. Biophys. Res. Commun. 495, 2071\u20132077 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58393_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2015.01.034","volume":"239","author":"M D\u2019Apolito","year":"2015","unstructured":"D\u2019Apolito, M. et al. Urea-induced ROS cause endothelial dysfunction in chronic renal failure. Atherosclerosis 239, 393\u2013400 (2015).","journal-title":"Atherosclerosis"},{"key":"58393_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000368195","volume":"51","author":"KL Liu","year":"2014","unstructured":"Liu, K. L. et al. Vascular function of the mesenteric artery isolated from thyroid hormone receptor-\u03b1 knockout mice. J. Vasc. Res. 51, 350\u2013359 (2014).","journal-title":"J. Vasc. Res."},{"key":"58393_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/hq0102.101098","volume":"22","author":"MJ Ryan","year":"2002","unstructured":"Ryan, M. J., Didion, S. P., Davis, D. R., Faraci, F. M. & Sigmund, C. D. Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arterioscler. Thromb. Vasc. Biol. 22, 42\u201348 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"58393_CR42","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1073\/pnas.1706168114","volume":"114","author":"S Timmermans","year":"2017","unstructured":"Timmermans, S., Van Montagu, M. & Libert, C. Complete overview of protein-inactivating sequence variations in 36 sequenced mouse inbred strains. Proc. Natl. Acad. Sci. USA 114, 9158\u20139163 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58393-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58393-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58393-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:24:07Z","timestamp":1670307847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58393-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58393"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58393-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1524"}}